<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Vomiting &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/meddra_pt/vomiting/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Fri, 19 Jun 2026 04:03:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Vomiting &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>A Study to Evaluate LY3537021 and a Drug Combination for Treating Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer</title>
		<link>https://clinicaltrials.eu/trial/a-study-to-evaluate-ly3537021-and-a-drug-combination-for-treating-nausea-and-vomiting-caused-by-chemotherapy-in-adults-with-cancer/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 15:09:06 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/a-study-to-evaluate-ly3537021-and-a-drug-combination-for-treating-nausea-and-vomiting-caused-by-chemotherapy-in-adults-with-cancer/</guid>

					<description><![CDATA[This study is being conducted to evaluate the effectiveness of a drug named LY3537021 in treating nausea and vomiting that occurs as a result of chemotherapy. These symptoms are common side effects in adults diagnosed with cancer, which is a broad term for neoplasms, or abnormal growths of cells in the body. The study aims [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This study is being conducted to evaluate the effectiveness of a drug named <b>LY3537021</b> in treating <b>nausea</b> and <b>vomiting</b> that occurs as a result of <b>chemotherapy</b>. These symptoms are common side effects in adults diagnosed with <b>cancer</b>, which is a broad term for <b>neoplasms</b>, or abnormal growths of cells in the body. The study aims to compare how well this new medication works when added to other existing treatments compared to a <b>placebo</b>.</p>
<p>The medications used during the study include several types of <b>antiemetic</b> drugs, which are substances used to prevent or reduce vomiting and nausea. These medications include <b>ondansetron</b>, <b>aprepitant</b>, <b>palonosetron</b>, <b>granisetron</b>, and <b>dexamethasone</b>. Some of these medicines are taken by mouth, while others may be given through an <b>intravenous</b> line, which is a small tube inserted into a vein to deliver medicine directly into the bloodstream, or via <b>subcutaneous</b> injection, which means the medicine is injected just under the skin.</p>
<p>During the course of the study, participants will be assigned to different groups to receive either the new medication or a <b>placebo</b> alongside their current anti-nausea treatments. The different groups will be monitored to see how many people experience a complete response, meaning they have no vomiting and do not need to take extra rescue medicine to manage their symptoms.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
